Zimmer Biomet (ZBH) PT Lowered to $105 at Citizens on an Operationally Mixed Quarter
Tweet Send to a Friend
Citizens analyst David Turkaly lowered the price target on Zimmer Biomet (NYSE: ZBH) to $105.00 (from $120.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
